Related content

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F.   Forlenza O. V.   Talib L. L.   Barbosa N. R.   Bottino C. M. C.  

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in patients with Alzheimer’s disease, vascular dementia and ischemic stroke

By Krzystanek E.   Krzystanek M.   Opala G.   Trzeciak H. I.   Siuda J.   Małecki A.  

Journal of Neural Transmission, Vol. 114, Iss. 8, 2007-08 ,pp. : 1033-1039

Springer Publishing Company

Access to resources Recommend Favorite

Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer’s Disease Brain: Implications for AD Pathogenesis

By Domenico Fabio   Cenini Giovanna   Sultana Rukhsana   Perluigi Marzia   Uberti Daniela   Memo Maurizio   Butterfield D.  

Neurochemical Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 727-733

Springer Publishing Company

Access to resources Recommend Favorite

The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease

By Melchor Jerry   Pawlak Robert   Chen Zulin   Strickland Sidney  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 287-289

Humana Press, Inc

Access to resources Recommend Favorite

Role of apoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathy

By Holtzman David  

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 147-155

Humana Press, Inc

Access to resources Recommend Favorite